Epithelial CEBPD activates fibronectin and enhances macrophage adhesion in renal ischemia-reperfusion injury.
Shen-Shin ChangChao-Chun ChengYing-Ren ChenFeng-Wei ChenYa-Min ChengJu-Ming WangPublished in: Cell death discovery (2024)
Ischemia-reperfusion injury (IRI) is a cause of acute kidney injury in patients after renal transplantation and leads to high morbidity and mortality. Damaged kidney resident cells release cytokines and chemokines, which rapidly recruit leukocytes. Fibronectin (FN-1) contributes to immune cell migration, adhesion and growth in inflamed tissues. CCAAT/enhancer-binding protein delta is responsive to inflammatory cytokines and stresses and plays functional roles in cell motility, extracellular matrix production and immune responses. We found that the expression of CCAAT/enhancer-binding protein delta was increased in renal epithelial cells in IRI mice compared with sham mice. Following IRI, the colocalization of FN-1 with the macrophage marker F4/80 was increased in renal injury model wild-type mice but was significantly attenuated in Cebpd-deficient mice. Inactivation of CEBPD can repress hypoxia-induced FN-1 expression in HK-2 cells. Moreover, the inactivation of CEBPD and FN-1 also reduces macrophage accumulation in HK-2 cells. These findings suggest that the involvement of CEBPD in macrophage accumulation through the activation of FN-1 expression and the inhibition of CEBPD can protect against renal IRI.
Keyphrases
- binding protein
- induced apoptosis
- ischemia reperfusion injury
- wild type
- cell migration
- poor prognosis
- extracellular matrix
- cell cycle arrest
- adipose tissue
- immune response
- oxidative stress
- end stage renal disease
- high fat diet induced
- biofilm formation
- endoplasmic reticulum stress
- type diabetes
- transcription factor
- signaling pathway
- stem cells
- dendritic cells
- escherichia coli
- long non coding rna
- chronic kidney disease
- clinical trial
- single cell
- peritoneal dialysis
- toll like receptor
- metabolic syndrome
- cell proliferation
- skeletal muscle
- staphylococcus aureus
- bone marrow
- endothelial cells
- pseudomonas aeruginosa
- prognostic factors
- cell therapy
- inflammatory response
- quality improvement